Literature DB >> 23519466

Fas-associated phosphatase 1 (Fap1) influences βcatenin activity in myeloid progenitor cells expressing the Bcr-abl oncogene.

Weiqi Huang1, Ling Bei, Elizabeth A Eklund.   

Abstract

Increased βcatenin activity correlates with leukemia stem cell expansion and disease progression in chronic myeloid leukemia (CML). We found previously that expression of the CML-related Bcr-abl oncoprotein in myeloid progenitor cells increases expression of Fas-associated phosphatase 1 (Fap1). This resulted in Fap1-dependent resistance to Fas-induced apoptosis in these cells. Fap1 also interacts with the adenomatous polyposis coli (Apc) protein, but the functional significance of this interaction is unknown. Apc participates in a complex that includes glycogen synthase kinase β (Gsk3β) and βcatenin. Assembly of this complex results in phosphorylation of βcatenin by Gsk3β, which facilitates βcatenin ubiquitination and degradation by the proteasome. In this study, we found increased association of Fap1 with the Apc complex in Bcr-abl(+) myeloid progenitor cells. We also found Fap1-dependent inactivation of Gsk3β and consequent stabilization of βcatenin in these cells. Consistent with this, Bcr-abl(+) cells exhibited a Fap1-dependent increase in βcatenin activity. Our studies identified Fap1-dependent Gsk3β inactivation as a molecular mechanism for increased βcatenin activity in CML.

Entities:  

Keywords:  Fas; Gene Regulation; Glycogen Synthase Kinase 3; Leukemia; βcatenin

Mesh:

Substances:

Year:  2013        PMID: 23519466      PMCID: PMC3642322          DOI: 10.1074/jbc.M112.429696

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Overexpression of beta-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators.

Authors:  K Kim; K M Pang; M Evans; E D Hay
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

2.  Solution structure of the PDZ2 domain from cytosolic human phosphatase hPTP1E complexed with a peptide reveals contribution of the beta2-beta3 loop to PDZ domain-ligand interactions.

Authors:  Guennadi Kozlov; Denis Banville; Kalle Gehring; Irena Ekiel
Journal:  J Mol Biol       Date:  2002-07-19       Impact factor: 5.469

3.  Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.

Authors:  Catriona H M Jamieson; Laurie E Ailles; Scott J Dylla; Manja Muijtjens; Carol Jones; James L Zehnder; Jason Gotlib; Kevin Li; Markus G Manz; Armand Keating; Charles L Sawyers; Irving L Weissman
Journal:  N Engl J Med       Date:  2004-08-12       Impact factor: 91.245

4.  The leukemia-associated fusion protein Tel-platelet-derived growth factor receptor β (Tel-PdgfRβ) inhibits transcriptional repression of PTPN13 gene by interferon consensus sequence binding protein (Icsbp).

Authors:  Weiqi Huang; Liping Hu; Ling Bei; Elizabeth Hjort; Elizabeth A Eklund
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

5.  Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder.

Authors:  S X Hao; R Ren
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

6.  Recruitment of CREB-binding protein by PU.1, IFN-regulatory factor-1, and the IFN consensus sequence-binding protein is necessary for IFN-gamma-induced p67phox and gp91phox expression.

Authors:  E A Eklund; R Kakar
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

7.  Characterization of a human macrophage-like cell line stimulated in vitro: a model of macrophage functions.

Authors:  J W Larrick; D G Fischer; S J Anderson; H S Koren
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

8.  Fas-associated phosphatase 1 mediates Fas resistance in myeloid progenitor cells expressing the Bcr-abl oncogene.

Authors:  Weiqi Huang; Ling Bei; Elizabeth A Eklund
Journal:  Leuk Lymphoma       Date:  2012-09-05

9.  SHP1 protein-tyrosine phosphatase inhibits gp91PHOX and p67PHOX expression by inhibiting interaction of PU.1, IRF1, interferon consensus sequence-binding protein, and CREB-binding protein with homologous Cis elements in the CYBB and NCF2 genes.

Authors:  B Kautz; R Kakar; E David; E A Eklund
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

10.  Cloning and characterization of PTPL1, a protein tyrosine phosphatase with similarities to cytoskeletal-associated proteins.

Authors:  J Saras; L Claesson-Welsh; C H Heldin; L J Gonez
Journal:  J Biol Chem       Date:  1994-09-30       Impact factor: 5.157

View more
  10 in total

1.  The role of Fas-associated phosphatase 1 in leukemia stem cell persistence during tyrosine kinase inhibitor treatment of chronic myeloid leukemia.

Authors:  W Huang; C-H Luan; E E Hjort; L Bei; R Mishra; K M Sakamoto; L C Platanias; E A Eklund
Journal:  Leukemia       Date:  2016-03-17       Impact factor: 11.528

2.  The Interferon Consensus Sequence Binding Protein (Icsbp/Irf8) Is Required for Termination of Emergency Granulopoiesis.

Authors:  Liping Hu; Weiqi Huang; Elizabeth E Hjort; Ling Bei; Leonidas C Platanias; Elizabeth A Eklund
Journal:  J Biol Chem       Date:  2015-12-18       Impact factor: 5.157

3.  14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia.

Authors:  Manuela Mancini; Elisa Leo; Ken-Ichi Takemaru; Virginia Campi; Fausto Castagnetti; Simona Soverini; Caterina De Benedittis; Gianantonio Rosti; Michele Cavo; Maria Alessandra Santucci; Giovanni Martinelli
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

4.  BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemia.

Authors:  Elisa Leo; Manuela Mancini; Michela Aluigi; Simona Luatti; Fausto Castagnetti; Nicoletta Testoni; Simona Soverini; Maria Alessandra Santucci; Giovanni Martinelli
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

Review 5.  Genetic alterations of protein tyrosine phosphatases in human cancers.

Authors:  S Zhao; D Sedwick; Z Wang
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

6.  Bcr-abl regulates Stat5 through Shp2, the interferon consensus sequence binding protein (Icsbp/Irf8), growth arrest specific 2 (Gas2) and calpain.

Authors:  Elizabeth E Hjort; Weiqi Huang; Liping Hu; Elizabeth A Eklund
Journal:  Oncotarget       Date:  2016-11-22

Review 7.  Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer.

Authors:  Soha Mcheik; Leticia Aptecar; Peter Coopman; Véronique D'Hondt; Gilles Freiss
Journal:  Biomolecules       Date:  2020-12-11

8.  Inhibition of Fas associated phosphatase 1 (Fap1) facilitates apoptosis of colon cancer stem cells and enhances the effects of oxaliplatin.

Authors:  Weiqi Huang; Ling Bei; Elizabeth A Eklund
Journal:  Oncotarget       Date:  2018-05-25

Review 9.  Chibby 1: a new component of β-catenin-signaling in chronic myeloid leukemia.

Authors:  Manuela Mancini; Simona Soverini; Gabriele Gugliotta; Maria Alessandra Santucci; Gianantonio Rosti; Michele Cavo; Giovanni Martinelli; Fausto Castagnetti
Journal:  Oncotarget       Date:  2017-09-22

Review 10.  Current Views on the Interplay between Tyrosine Kinases and Phosphatases in Chronic Myeloid Leukemia.

Authors:  Christian Boni; Claudio Sorio
Journal:  Cancers (Basel)       Date:  2021-05-12       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.